Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1987 1
1991 2
1994 4
1997 1
2000 1
2002 1
2004 1
2006 1
2007 2
2008 2
2009 4
2010 5
2011 4
2012 3
2013 3
2014 7
2015 8
2016 3
2017 2
2018 4
2019 5
2020 6
2021 7
2022 14
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Feb 19:S0161-6420(24)00134-9. doi: 10.1016/j.ophtha.2024.02.014. Online ahead of print. Ophthalmology. 2024. PMID: 38382813 Free article.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2023 Dec 28:S0161-6420(23)00933-8. doi: 10.1016/j.ophtha.2023.12.026. Online ahead of print. Ophthalmology. 2023. PMID: 38158159 Free article.
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Exudation in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System or Monthly Injections.
Akhlaq A, Williams D, Clark WL, Khan H, Khanani AM, Walden L, Awh C, Graff JT, Graff JM, Wakabayashi T, Regillo C, Maass KF, Callaway NF, Gune S, Campochiaro PA. Akhlaq A, et al. Among authors: awh c. Am J Ophthalmol. 2024 Feb;258:158-172. doi: 10.1016/j.ajo.2023.07.003. Epub 2023 Jul 13. Am J Ophthalmol. 2024. PMID: 37453472 Free article.
Coats Plus Syndrome in a Premature Infant, With a Focus on Management.
Sears AE, Awh CC, Kunhiabdullah S, Sears JE, Mammo DA. Sears AE, et al. Among authors: awh cc. J Vitreoretin Dis. 2022 Oct 17;7(1):74-78. doi: 10.1177/24741264221129430. eCollection 2023 Jan-Feb. J Vitreoretin Dis. 2022. PMID: 37008390 Free PMC article.
Opportunity Cost of Retinal Detachment Surgery vs Office-Based Patient Care.
Leung EH, Leder HA, Patel S, Reddy R, Boucher N, Sharma C, Blim J, Awh C, Hahn P; American Society of Retina Specialists Health Economics Committee. Leung EH, et al. Among authors: awh c. J Vitreoretin Dis. 2022 Jul 16;6(4):278-283. doi: 10.1177/24741264221098669. eCollection 2022 Jul-Aug. J Vitreoretin Dis. 2022. PMID: 37007922 Free PMC article.
95 results